Home › Research › Clinical trials
Clinical trials
Every Alzheimer's trial in our copy of the ClinicalTrials.gov registry — completed, running and abandoned. Filter it, then follow the link to the official record.
If you are thinking about joining a trial
A listing here is a record that a study was registered. It is not a recommendation, and it does not mean the study is still recruiting or that anyone is eligible. Registry entries go stale.
Talk to the treating doctor first, then contact the study team listed on the official ClinicalTrials.gov record. The NIA's free referral line can help you look: 1-800-438-4380, weekdays, English and Spanish.
Showing 5,651–5,675 of 7,816 matching trials · page 227 of 313, 25 per page.
Sorted by the date the registry record was last updated, newest first. This page never loads all 7,816 rows at once — use the CSV download if you want the whole file.
| Trial | Phase | Status | Enrolled | Sponsor | Last updated |
|---|---|---|---|---|---|
|
Life Enhancing Activities for Family Caregivers NCT01825681 Positive Affect Runs in: United States · 1 site |
NA other |
COMPLETED | 175 | University of California, San Francisco OTHER |
2019-08-05 |
|
A Safety and Tolerability Study of GB301 NCT03865017 Regulatory T cells; Saline Runs in: Australia · 1 site |
PHASE1|PHASE2 other |
UNKNOWN | 20 | VTBIO Co. LTD INDUSTRY |
2019-08-05 |
|
Virtual Reality Based Cognitive Training Program in Mild Cognitive Impairment NCT04045483 Virtual reality based cognitive training Runs in: South Korea · 2 sites |
NA other |
UNKNOWN | 30 | Inha University Hospital OTHER |
2019-08-05 |
|
Adaptive Cognitive Training in Healthy Older Adults NCT02205710 Computerized cognitive training; Computerized games Runs in: Canada · 1 site |
NA other |
COMPLETED | 99 | Bruyère Health Research Institute. OTHER |
2019-08-02 |
|
REspectful CAring for the AGitated Elderly NCT03507504 SCU-B Runs in: Belgium; France; Germany; Greece; Italy; Norway; Switzerland · 12 sites |
NA other |
UNKNOWN | 500 | Fondazione Europea di Ricerca Biomedica Ferb Onlus OTHER |
2019-08-01 |
|
A Study to Evaluate Albumin and Immunoglobulin in Alzheimer's Disease NCT01561053 Albumin 5%; Albumin 20%; Immunoglobulin Runs in: Spain; United States · 40 sites |
PHASE2|PHASE3 other |
COMPLETED | 347 | Instituto Grifols, S.A. INDUSTRY |
2019-07-31 |
|
Long Term Memory Preoperative Preparation Reduce Post Operative Behavioral Change NCT04039269 Preoperative video information Runs in: Thailand · 1 site |
NA other |
UNKNOWN | 192 | Prince of Songkla University OTHER |
2019-07-31 |
|
Endothelial Facilitation in Alzheimer's Disease NCT01439555 Simvastatin; L-Arginine; Tetrahydrobiopterin Runs in: United States · 1 site |
PHASE2 other |
COMPLETED | 11 | University of Massachusetts, Worcester OTHER |
2019-07-30 |
|
Evaluation of an Innovative Information, Training and Social Support Intervention "INFOSADEM" to Principal Caregivers of Dementia Patients Living at Home NCT04036955 INFOSA-DEM |
NA other |
COMPLETED | 160 | Hospital Clinic of Barcelona OTHER |
2019-07-30 |
|
Intervention to Reduce Sedentary Time NCT02878486 Jawbone Up; Physical Activity Education; ActivPAL Runs in: United States · 1 site |
NA other |
COMPLETED | 6 | University of Kansas Medical Center OTHER |
2019-07-29 |
|
A Comparison Study of the Efficacy of Quetiapine and Haloperidol in Agitated Adults in Emergency Room NCT00457366 Quetiapine; Haloperidol; Lorazepam; Cogentin Runs in: United States · 1 site |
PHASE4 other |
COMPLETED | 72 | University of Southern California OTHER |
2019-07-26 |
|
Pre-hospital Agitation and Sedation Trial: A Randomized Controlled Trial of Haloperidol Versus Midazolam for the Sedation of the Agitated Patient NCT01501123 Haloperidol; Midazolam Runs in: United States · 1 site |
NA other |
COMPLETED | 10 | Catholic Health East OTHER |
2019-07-24 |
|
Telemedicine Intervention to Improve Cognitive Function NCT02248649 Structured physical activity; Health education Runs in: United States · 1 site |
NA other |
COMPLETED | 160 | VA Office of Research and Development OTHER_GOV |
2019-07-24 |
|
A Study of Crenezumab in Participants With Mild to Moderate Alzheimer Disease NCT02353598 Crenezumab dose level 1; Crenezumab dose level 2; Crenezumb dose le... Runs in: United States · 13 sites |
PHASE1 anti-amyloid-antibody |
COMPLETED | 77 | Genentech, Inc. INDUSTRY |
2019-07-24 |
|
Heidelberg In Vivo Confocal Microscopy to Evaluate the Ocular Surface Disorders of Healthy and Diseased Individuals NCT04025801 Runs in: Taiwan · 1 site |
NA other |
UNKNOWN | 400 | National Taiwan University Hospital OTHER |
2019-07-24 |
|
Cognitive Benefits of Treating Sleep Apnea in Parkinson's Disease NCT00492115 Continuous positive airway pressure (CPAP); Placebo CPAP Runs in: United States · 1 site |
NA other |
COMPLETED | 98 | University of California, San Diego OTHER |
2019-07-23 |
|
Effects of Atomoxetine in Mild Cognitive Impairment NCT01522404 Atomoxetine; Placebo Runs in: United States · 1 site |
PHASE2 other |
COMPLETED | 39 | Emory University OTHER |
2019-07-23 |
|
Platelet Reactivity, B-amyloid, MOTS-c and Mortality of Type II Diabetics With CAD NCT04027712 Runs in: Greece · 1 site |
NA other |
UNKNOWN | 120 | University of Athens OTHER |
2019-07-23 |
|
Investigating the Impact of Multi-sensory Environments on Behavior During Assisted Bathing for Veterans With Dementia NCT03303638 Multi-sensory Environment Runs in: United States · 2 sites |
NA other |
COMPLETED | 11 | University of Florida OTHER |
2019-07-22 |
|
A Safety Study of LY2886721 Multiple Doses in Healthy Subjects NCT01227252 LY2886721; Placebo Runs in: United States · 1 site |
PHASE1 other |
COMPLETED | 42 | Eli Lilly and Company INDUSTRY |
2019-07-19 |
|
Consumption of Potatoes, Avocados and Chickpeas and Cognitive Function in Older Adults NCT01620567 avocado; potato or chickpea Runs in: United States · 1 site |
NA other |
COMPLETED | 48 | Tufts University OTHER |
2019-07-19 |
|
A Study of LY2886721 in Healthy Participants and Participants Diagnosed With Alzheimer's Disease NCT01807026 LY2886721; Placebo Runs in: United States · 1 site |
PHASE1 other |
COMPLETED | 36 | Eli Lilly and Company INDUSTRY |
2019-07-19 |
|
Pilot Study Person-centred Tablet Intervention NCT04026061 FMA group; Control group Runs in: Netherlands · 1 site |
NA other |
COMPLETED | 40 | Saxion University of Applied Sciences OTHER |
2019-07-19 |
|
Online Support Program for Dementia Caregivers NCT04026919 OK EN CASA-ZAINDOO Runs in: Spain · 2 sites |
NA other |
UNKNOWN | 250 | University of the Basque Country (UPV/EHU) OTHER |
2019-07-19 |
|
Biomarkers in Neural Disorders NCT02761707 Electrical Brainstem Responses; Olfactory Tests; Visual Deprivation... Runs in: United States · 1 site |
NA other |
COMPLETED | 54 | University of Pennsylvania OTHER |
2019-07-18 |
This table is wider than a phone screen — swipe it sideways to see the rest.
Where these trials come from
- Registry
- ClinicalTrials.gov, pulled through their public API (v2)
- Trials in the file
- 7,816
- Source file
- trials.csv (3.8 MB, 7816 rows)
- Basis
- Measured These are registry records as submitted by each study's sponsor.
What could make this misleading
Sponsors enter their own data and do not always keep it current, so "recruiting" can be out of date by months or years. Enrollment figures may be targets rather than actual numbers; the downloaded file says which for each trial. Trials that were never registered do not appear at all, and the intervention class is this project's own grouping, not the registry's.
Always check the official record before acting on anything here. This is a summary, not medical advice.
From the research library
The highest-scoring studies we hold on this subject, each summarised in plain English. Scores are alzhub's usefulness score, not a verdict on the science.
Clinical trials
- MINocyclinE to Reduce inflammation and blood-brain barrier leakage in small Vessel diseAse (MINERVA): A phase II, randomized, double-blind, placebo-controlled experimental medicine trial
- Safety and efficacy of crenezumab in cognitively unimpaired carriers of the PSEN1Glu280Ala mutation at risk for autosomal-dominant Alzheimer's disease in Colombia (API ADAD Colombia Trial): a phase 2, randomised, double-blind, placebo-controlled trial
- Study of mirtazapine for agitated behaviours in dementia (SYMBAD): a randomised, double-blind, placebo-controlled trial
- Randomized, double-blind study of zervimesine in mild to moderate Alzheimer's disease
- Efficacy assessment of an active tau immunotherapy in Alzheimer's disease patients with amyloid and tau pathology: a post hoc analysis of the "ADAMANT" randomised, placebo-controlled, double-blind, multi-centre, phase 2 clinical trial